This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

General News

Sep. 20, 2016

Metacrine appoints Dr. Song president, CEO, director

Ken Song, M.D., most recently was co-founder and chief executive officer of Ariosa Diagnostics, which was acquired by Roche in 2015 for $625 million.

Metacrine, Inc., a biotechnology company focused on developing innovative therapeutics in metabolic disease through advances in endocrine research, announced the appointment of Ken Song, M.D., as its new president, chief executive officer and director.

He most recently was co-founder and chief executive officer of Ariosa Diagnostics, which was acquired by Roche in 2015 for $625 million.

"Ken's proven leadership, track record and broad expertise serving the life science communi...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up